Global Viral Clearance and Viral Testing Services Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2030
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download Sample
Viral clearance refers to the process of removing or inactivating viruses from biological products, such as vaccines, therapeutic proteins, and blood products, to ensure their safety for use in humans. It involves various steps, including filtration, chromatography, and inactivation methods, to eliminate or reduce viral contaminants. Viral clearance studies are conducted to demonstrate the effectiveness of these processes and provide assurance that the final product is free from harmful viruses.
IMPACT OF COVID 19
Government across the globe have curbed their spend on technology to tackle Covid-19 challenges
Covid-19 pandemic had a positive impact on the market where the demand for viral Clearance increased. Diagnostic laboratories and testing centers experienced a significant increase in testing volumes, requiring them to scale up their capacity to meet the demand.
The long-term impact of COVID-19 on the viral clearance and viral testing services market remains uncertain. The pandemic has underscored the importance of testing and surveillance, which led to sustained investments in viral testing infrastructure, increased awareness, and preparedness for future viral outbreaks.
Market Growth Projections
The viral clearance and viral testing services market is projected to grow at CAGR of 14.2%, with market reaching a projected market size of USD 3,480.8 million by the year 2030. The high demand can be attributed to factors such as growing prevalence of viral diseases, stringent government regulations, increasing investment in research and development and others.
Driving forces for the market
Increasing prevalence of viral diseases
The rising incidence of viral infections, such as HIV, hepatitis, influenza, and COVID-19, is driving the demand for viral testing services. Effective viral clearance processes are also essential to ensure the safety of biopharmaceuticals and prevent the transmission of viral contaminants. In addition to this Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have established guidelines and regulations for viral clearance and testing. Compliance with these regulations drives the market as manufacturers seek to demonstrate the safety and efficacy of their products.
Restraints
High cost still remains one of the restraints in the market . Viral clearance and testing services can be expensive, especially when advanced technologies and specialized expertise are involved. The high cost can limit the accessibility and affordability of these services, particularly in resource-limited settings or for individuals without adequate healthcare coverage.
Scale of Operation:
The scale of operation segment is sub divided into clinical phase, discovery phase and pre clinical phase. Within these category the clinical phase is expected to have the largest market share, where the segment will contribute approx. 55% to the market in the year 2023 and the category will continue to dominate the market share during the forecast period.
Regional Level Analysis
The report categories the viral Clearance and Viral Testing Services market in four regions: North America, Europe, Asia Pacific and rest of the world. North American leads in terms of the highest market share where the region alone contributes~40% to the global Viral Clearance and Viral Testing Services market in the year 2023 and the same trend is expected to continue during the forecast period.
Market Players Covered
- Charles River Laboratories
- Eurofins Scientific
- Syngene International
- WuXi Biologics
- MilliporeSigma
- Nelson Labs
- Vironova
- Microbac Laboratories
- Texcell
- Creative Biolabs
- JADE Biomedical
| Report Components | Details |
|---|---|
| Base Year | 2022 |
| Forecast Period | 2023 – 2030 |
| Quantitative Units | Revenue in US $ |
| Drivers |
|
| Challenges |
|
| Scale of Operation |
|
| By Method |
|
| By End User |
|
| By Region |
|
| Countries Covered | U.S. and Canada in North America, Germany, Italy, France, UK, Sapim, Rest of Europe in Europe, China, Japan, Australia, India, South Korea, , Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Middle East and Africa (MEA) and Latin America as part of Rest of the World |
Table of Contents
1...... Report Overview
2...... Executive Summary
2.2.1 all that is covered in the report
2.2.2 viral clearance and viral testing services market at a glance
2.2.3 key marketplayers in the marketplace
3...... viral CLEARANCE AND VIRAL TESTING SERVICES market forces
3.1 Introduction
3.2 drivers
3.3 restraints
3.4 opportunities
3.4 challenges
3.5 porters five forces model
3.5.1 threat of new entrants
3.5.2 Threat of substitution
3.5.3 buyers power
3.5.4 suppliers power
3.6 macro economic factors
3.6.1 regulatory
3.6.2 economic
3.6.3 legal
3.6.4 technological
3.6.5 environmental
3.7 covid-19 impact
3.8 recession impact
3.9 russia-ukraine war impact
4...... Viral Clearance and Viral Testing Services, By scale of operation
4.1 Introduction
4.2 discovery phase utility
4.3 clinical phase transportation
4.4 pre clinical phase
5...... Viral Clearance and Viral Testing Services MARKET, By method
5.1 Introduction
5.2 viral detection
5.3 viral inactivation
5.4 viral removal
6...... VIRAL CLEARANCE AND VIRAL TESTING SERVICES MARKET, By end user
6.1 Introduction
6.2 Biotechnology and Pharmaceuticals Companies
6.3 Academic/Research Institutes
7.... north america Viral Clearance and Viral Testing Services MARKET, By segment
7.1 Introduction
7.2 by scale of operation
7.2.1 discovery phase
7.2.2 preclinical phase
7.2.3 clinical phase
7.3 by method
7.3.1 viral detection
7.3.2 viral inactivation
7.3.3 viral removal
7.4 by end user
7.4.1 Biotechnology and Pharmaceuticals Companies
7.4.2 Academic/Research Institutes
7.5 by country
7.5.1 us
7.5.2 canada
8.... europe Viral Clearance and Viral Testing Services MARKET, By segment
8.1 Introduction
8.2 by scale of operation
8.2.1 discovery phase
8.2.2 preclinical phase
8.2.3 clinical phase
8.3 by method
8.3.1 viral detection
8.3.2 viral inactivation
8.3.3 viral removal
8.4 by end user
8.4.1 Biotechnology and Pharmaceuticals Companies
8.4.2 Academic/Research Institutes
8.5 by country
8.5.1 germany
8.5.2 Uk
8.5.3 France
8.5.4 italy
8.5.5 spain
8.5.6 rest of europe
9.... asia pacific Viral Clearance and Viral Testing Services MARKET, By segment
9.1 Introduction
9.2 by scale of operation
9.2.1 discovery phase
9.2.2 preclinical phase
9.2.3 clinical phase
9.3 by method
9.3.1 viral detection
9.3.2 viral inactivation
9.3.3 viral removal
9.4 by end user
9.4.1 Biotechnology and Pharmaceuticals Companies
9.4.2 Academic/Research Institutes
9.5 by country
9.5.1 china
9.5.2 japan
9.5.3 south korea
9.5.4 australia
9.5.5 india
9.5.6 rest of apac
10.. rest of the world Viral Clearance and Viral Testing Services MARKET, By segment
10.1 Introduction
10.2 by scale of operation
10.2.1 discovery phase
10.2.2 preclinical phase
10.2.3 clinical phase
10.3 by method
10.3.1 viral detection
10.3.2 viral inactivation
10.3.3 viral removal
10.4 by end user
10.4.1 Biotechnology and Pharmaceuticals Companies
10.4.2 Academic/Research Institutes
10.5 by country
10.5.1 middle east and africa
10.5.2 latin america
11.... competitive analysis
11.1 Competitive Quadrant – Market Leaders Analysis
11.2 Market Share Analysis – Top 5 Key Vendors
12.... Company Profiles
12.1 Charles River Laboratories
12.2 Eurofins Scientific
12.3 Syngene International
12.4 WuXi Biologicselectric
12.5 MilliporeSigma
12.6 Nelson Labs
12.7 Vironova
12.8 Microbac Laboratories
12.9 Texcell
12.10 Creative Biolabs
12.11 JADE Biomedical
List of TableS
No table of figures entries found.
List of FIGURES
FIGURE 1 VIRAL CLEARANCE AND VIRAL TESTING SERVICES MARKET: RESEARCH DESIGN 9
FIGURE 2 VIRAL CLEARANCE AND VIRAL TESTING SERVICES market snapshot, 2016–2024 14
FIGURE 3 SEGMENT HOLDS LARGEST MARKET SHARE AMONG SERVICE MODELS IN 2019 15
FIGURE 4 STORAGE, BACKUP, AND DISASTER RECOVERY HOLDS LARGEST MARKET SHARE AMONG WORKLOADS IN 2019 15
FIGURE 5 INFRASTRUCTURE AS A SERVICE segment TO GROW AT the HIGHEST RATE during the forecast period 18
FIGURE 6 vertical to grow at the highest rate during the forecast period 21
FIGURE 7 segment to grow at the highest rate during the forecast period 25
FIGURE 8 AWS: COMPANY SNAPSHOT 31
FIGURE 9 AWS: swot analysis 33
Global Viral Clearance and Viral Testing Services Market Segmentation
Viral Clearance and Viral Testing Services by Scale of Operation: Market Size & Forecast 2023-2032
- Discovery Phase
- Preclinical Phase
- Clinical Phase
Viral Clearance and Viral Testing Services by Method: Market Size & Forecast 2023-2032
- Viral Detection
- Viral Inactivation
- Viral Removal
Viral Clearance and Viral Testing Services by End User: Market Size & Forecast 2023-2032
- Biotechnology and Pharmaceuticals
- Academic/Research Institutes
Viral Clearance and Viral Testing Services by Geography: Market Size & Forecast 2023-2032
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Major Players:
- Charles River Laboratories
- Eurofins Scientific
- Syngene International
- WuXi Biologics
- MilliporeSigma
- Nelson Labs
- Vironova
- Microbac Laboratories
- Texcell
- Creative Biolabs
- JADE Biomedical
